Carlo Baggio - Concepedia

Author

Carlo Baggio

University of California, Riverside ORCID

Also Known As

C. Baggio, Carlo Baggio

Publications

689

Citations

H-Index

Concepts

All Affiliations

University of California, Riverside Discovery Institute Sanford Burnham Prebys Medical Discovery Institute Interuniversity Consortium for Magnetic Resonance University of California San Diego

About

Carlo Baggio is an author at University of California, Riverside specializing in medicine, drug discovery, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	304
2	Biochemistry	9	9	251
3	Natural Sciences	7	7	207
4	Biomolecular Engineering	4	4	116
5	Engineering	2	2	44

Carlo Baggio

Publications

651

Citations

H-Index

Page 1

	Year	Citations
Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues Luca Gambini, Carlo Baggio, Parima Udompholkul, Journal of Medicinal Chemistry	2019	136
Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate Ahmed F. Salem, Si Wang, Sandrine Billet, Journal of Medicinal Chemistry	2018	65
Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy Carlo Baggio, Parima Udompholkul, Luca Gambini, Journal of Medicinal Chemistry Protein AssemblyApoptosis ProteinApoptosisCell DeathMolecular Biology	2019	60
Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach Carlo Baggio, Luca Gambini, Parima Udompholkul, Journal of Medicinal Chemistry Combinatorial ChemistryPharmaceutical ScienceChemistryChemical BiologyPharmaceutical Chemistry	2018	45
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents Elisa Barile, Guya Diletta Marconi, Surya K. De, ACS Chemical Biology ApoptosisCell DeathCancer BiologyTumor BiologyTumor Immunity	2016	41
Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1 Luca Gambini, Parima Udompholkul, Carlo Baggio, Journal of Medicinal Chemistry	2021	38
Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease Carlo Baggio, Jalene V. Velazquez, Marco Fragai, Journal of Medicinal Chemistry	2020	37
Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity <i>in Vitro</i> and in Cell Luca Gambini, Ahmed F. Salem, Parima Udompholkul, ACS Chemical Biology EngineeringTumor BiologyMolecular PharmacologyEpha2 OverexpressionStructure-based Design	2018	29
Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys‐Covalent Antagonists of Protein‐Protein Interactions Luca Gambini, Parima Udompholkul, Ahmed F. Salem, ChemMedChem Protein ChemistryProteinlipid InteractionAryl-sulfonyl FluoridesBiochemistryNatural Sciences	2020	27
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist Parima Udompholkul, Ana Garza-Granados, Giulia Alboreggia, Journal of Medicinal Chemistry	2023	26

Page 1